Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person AMER1 R353* [cytosol]

Class:Id	EntityWithAccessionedSequence:9663939
_displayName	AMER1 R353* [cytosol]
_timestamp	2025-10-02 22:23:39
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9663940] Rothfels, Karen, 2019-10-18
crossReference	[DatabaseIdentifier:9663937] COSMIC:COSV57654256
disease	[Disease:1500689] cancer [Disease:9662153] colon adenocarcinoma [Disease:4791250] colorectal cancer
endCoordinate	352
hasModifiedResidue	[NonsenseMutation:9663932] Nonsense mutation at L-arginine 353
literatureReference	[LiteratureReference:5251462] WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact
modified	[InstanceEdit:9967563] D'Eustachio, Peter, 2025-10-02
name	AMER1 R353* FAM123B WTX
referenceEntity	[ReferenceGeneProduct:228772] UniProt:Q5JTC6 AMER1 [Homo sapiens]
species	[Species:48887] Homo sapiens
stableIdentifier	[StableIdentifier:9663941] R-HSA-9663939.2
startCoordinate	1
(hasCandidate)	[CandidateSet:4839741] truncated AMER1 mutants [cytosol] [Homo sapiens]
(updatedInstance)	[_UpdateTracker:9972225] Update Tracker - [EntityWithAccessionedSequence:9663939] AMER1 R353* [cytosol] - v95:[modifyEndCoordinate]
[Change default viewing format]

No pathways have been reviewed or authored by AMER1 R353* [cytosol] (9663939)